You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
4 September 2026 - Australian biopharmaceutical company Immuron Limited (ASX: IMC; NASDAQ: IMRN), which develops and commercialises targeted polyclonal antibodies for infectious diseases, announced on Friday that it has signed an exclusive US distrib...
4 September 2026 - Invagen Pharmaceuticals Inc, a wholly owned subsidiary of India-based pharmaceutical company Cipla Limited (BSE:500087) (NSE:CIPLA), announced on Thursday that it has entered into a strategic partnership with China-based Qilu Pharm...
4 September 2026 - Molecular diagnostics company Cepheid, a Danaher (NYSE:DHR) company, announced on Thursday that it has received Emergency Use Listing (EUL) from the World Health Organization (WHO) for the Xpert Hemorrhagic Fever Panel test to supp...
4 September 2026 - Kali Therapeutics, a clinical-stage biotechnology company focused on new therapies for autoimmune and inflammatory diseases, announced on Thursday that the US Food and Drug Administration (FDA) has cleared the company's Invest...
4 September 2026 - Thryv Therapeutics Inc, a clinical-stage biopharmaceutical company advancing selective SGK1 inhibitors, announced on Thursday that it has entered into an exclusive, worldwide, royalty-bearing patent and know-how licence agreement w...
3 September 2026 - EpiVax Inc, a provider of immunogenicity assessment and sequence optimisation for biologic therapeutics and vaccines, announced on Wednesday the release of AI-enabled enhancements to ISPRI, its proprietary in silico platform for as...
3 September 2026 - Foventa Therapeutics, a biotechnology company focused on novel therapies for retinal vascular diseases, announced on Wednesday that it has further strengthened its management team with the appointments of Dr Zaiba Malik as chief me...